Topamax and Raynaud's phenomenon - from FDA reports


Summary

Raynaud's phenomenon is found among people who take Topamax, especially for people who are female, 30-39 old , have been taking the drug for 10+ years, also take medication Neurontin, and have Migraine . We study 31,957 people who have side effects while taking Topamax from FDA. Among them, 25 have Raynaud's phenomenon. Find out below who they are, when they have Raynaud's phenomenon and more.

What to expect?

If you take Topamax and have Raynaud's phenomenon, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Topamax and have Raynaud's phenomenon

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Topamax

Topamax has active ingredients of topiramate. It is often used in migraine. (latest outcomes from Topamax 35,600 users)

Raynaud's Phenomenon

Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas) has been reported by people with osteoporosis, high blood pressure, rheumatoid arthritis, multiple sclerosis, attention deficit hyperactivity disorder (latest reports from 4,164 Raynaud's phenomenon patients).

On Jan, 28, 2017

31,957 people reported to have side effects when taking Topamax.
Among them, 25 people (0.08%) have Raynaud's Phenomenon


Number of reports submitted per year:

Could Topamax cause Raynaud's phenomenon?

Time on Topamax when people have Raynaud's Phenomenon *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 100 %

Gender of people who have Raynaud's Phenomenon when taking Topamax *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Raynaud's Phenomenon when taking Topamax *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 10 %
  • 20-29: 10 %
  • 30-39: 40 %
  • 40-49: 20 %
  • 50-59: 20 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Migraine (8 people, 32.00%)
  • Narcolepsy (3 people, 12.00%)
  • Multiple Sclerosis (2 people, 8.00%)
  • Insomnia (2 people, 8.00%)
  • Hormone Replacement Therapy (2 people, 8.00%)

Top co-used drugs for these people *:

  • Neurontin (5 people, 20.00%)
  • Synthroid (3 people, 12.00%)
  • Hyzaar (3 people, 12.00%)
  • Celexa (3 people, 12.00%)
  • Baclofen (3 people, 12.00%)

Top other side effects for these people *:

  • Fibromyalgia (5 people, 20.00%)
  • Migraine (3 people, 12.00%)
  • Joint Pain (3 people, 12.00%)
  • Headache (3 people, 12.00%)
  • Fatigue (3 people, 12.00%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Raynaud's phenomenon when taking Topamax?

Browse all side effects of Topamax

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Raynaud's phenomenon

Raynaud's phenomenon

Could your condition cause Raynaud's phenomenon

Raynaud's phenomenon

Related studies

Can you answer these questions?

More questions for: Topamax, Raynaud's phenomenon

You may be interested in these reviews

More reviews for: Topamax, Raynaud's phenomenon